The NHS Redress bill (www.parliament.uk) is the next step in the government's oft-stated commitment to improve the handling of clinical complaints within the NHS. It represents a logical progression to the principles set out in "An Organisation with a Memory" (2000) and "Making Amends" (2003) , both excellent reports produced by the Chief Medical Officer.
All those involved with clinical negligence would agree that the current system is expensive and slow, while often failing to meet the needs of the patient; these usually include an apology, explanation and an assurance that action will be taken so that the problem does not repeat itself. Additionally, the system is adversarial with a heavy emphasis on proving blame on the part of the individual practitioner rather than the more relevant system failures that are responsible; in so doing it discourages frank reporting and discussion of problems that, having once occurred, can then be prevented. Doubtless the £150 million of legal costs in the clinical negligence bill of £500 million for 2004-2005 has also helped to focus government minds.
The scheme places an obligation on the Trust or Service Provider to monitor outcomes, initiate investigations when an adverse clinical event has occurred and to inform the patient even if they are not yet aware of a potential problem. Appropriate action will follow "after consultation with the NHSLA"; this may include an apology, explanation and compensa-tion up to a limit of £20,000. The patient will also receive independent advice, from a solicitor who receives a flat fee provided by the NHSLA, as to whether the offer should be accepted or declined. Acceptance of an offer of compensation does not include an admission of liability but does prohibit the right of the patient subsequently to take legal action.
So far, so good -what are the potential problems that can be anticipated? As always, there is an obvious conflict between the government's desire to devolve patient handling to as local a level as possible and their wish to keep a very tight rein on the purse strings. It is not clear if the NHSLA will continue to meet the costs through central funding or if the Provider will have to find the money. The former is clearly preferable at a time when many trusts are facing financial meltdown. This unhappy situation seems unchanged despite the money recently thrown at the NHS -where has it all gone? Although the Service Provider will be responsible for monitoring and investigating potential problems any subsequent action can only be taken after consultation with the NHSLA. I wonder if they will be more concerned with the bottom line of the balance sheet, rather than helping to facilitate a true no-blame culture within the Health Care Sector from which lessons can be learned and action taken to reduce the continuing high level of adverse clinical events.
Will there also be a conflict between the advice provided to patients by, presumably, Litigation Authority-approved solicitors and the rather jolly band of claimant lawyers that have done so much to enrich my life over the last 15 years? Although the financial motive traditionally is said not to be a major driving force in adult clinical negligence litigation, money talks (or swears, according to Bob Dylan); few of us are immune to its allure. It would be ironic indeed if the proactive efforts of hospital trusts were to reveal large numbers of hitherto-unsuspected adverse events which would then lead to independent legal action without the costs limitation that the new bill anticipates.
Although this is not "no fault compensation" the issue of clinical responsibility for an adverse event will pose some difficult questions. The Medical Defence Union has already pointed out that their members should not be unfairly blamed for an unexpected outcome, which experience has shown is more usually the result of multiple system failures rather than an episode of irresponsible madness by the doctor or nurse. Doctors, not unreasonably, need to protect their professional reputations and will not allow themselves to be unfairly traduced; any doctors without independent medical protection will need to correct this anomaly by 2008, when the scheme is likely to take effect.
Finally, AvMA have recently pointed out that the definition of what constitutes a "medical accident" needs to be revisited and refined. A "wrong medical decision" may involve, for example, the level or continuation of care provided to a child or adult and issues such as new drug usage or resource allocation are likely to need re-examination because of the changes in European Law which will have increasingly important effects. These types of issues will never be addressed by the new scheme although, to be fair, perhaps this was never the intention.
If the scheme provides a quick, comprehensive and proportionate solution for straightforward adverse outcomes then it is to be welcomed; the more costly and complex cases can be dealt with through the courts as before. Service providers such as NHS Trusts and commercial organisations will need to devote substantial resources to establish the monitoring and assessment systems needed to detect potential adverse outcomes experienced by patients; the numbers are huge and the workload should not be underestimated. The opportunity to feed back this new information via Risk Management and Clinical Governance must not be missed, either by the Trust involved or the Litigation Authority itself. It seems unlikely that clinical negligence lawyers should be seeking urgent retraining at this stage but I would be happy to be proven wrong.
